MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Vor Biopharma Inc. (NASDAQ: VOR)
Organization & Developments: Vor Biopharma
Parents
Vor Biopharma Inc. (NASDAQ: VOR)
Children
* Engineered hematopoietic stem cells that unleash the potential of targeted therapies. Hide healthy cells, expose cancer cells.
2020: Vor Biopharma and Metagenomi to Collaborate on Engineered Hematopoietic Stem-Cell Therapies
2022: Vor Biopharma (VOR) Investor Presentation -Slideshow_ seekingalpha.com
2025: Vor Bio to wind down, halting cell therapy trials and shedding most staff
2025: Vor Biopharma: Chinese Win Sets The Direction, But There Is Still Much Uncertainty
2025: Vor Biopharma: Not So Sure About This Surge, And Do Mind The Warrants
2025: Vor Biopharma: Short On Cash, Too Much Uncertainty For Now
Jumps
Finance & Acquisitions: Vor Biopharma
Key People: Vor Biopharma